Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice

By Hordnes K.   Tynning T.   Brown T.A.   Haneberg B.   Jonsson R.  

Vaccine, Vol. 15, Iss. 11, 1997-08 ,pp. : 1244-1251

Elsevier

Access to resources Recommend Favorite

Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope

By Olive C.   Clair T.   Yarwood P.   Good M.F.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2816-2825

Elsevier

Access to resources Recommend Favorite

The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains

By Ala'Aldeen D.A.A.   Borriello S.P.  

Vaccine, Vol. 14, Iss. 1, 1996-01 ,pp. : 49-53

Elsevier

Access to resources Recommend Favorite

A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein

By Nakamura Y.   Kameoka M.   Tobiume M.   Kaya M.   Ohki K.   Yamada T.   Ikuta K.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 489-496

Elsevier

Access to resources Recommend Favorite

Recombinant, octavalent group A streptococcal M protein vaccine

By Dale J.B.   Simmons M.   Chiang E.C.   Chiang E.Y.  

Vaccine, Vol. 14, Iss. 10, 1996-07 ,pp. : 944-948

Elsevier

Access to resources Recommend Favorite